Members |
targetComponentId |
Cyst of Bartholin's gland |
Cyst of Bartholin's gland duct |
Cyst of bursa |
Bursal cyst |
cysta i testiklar |
Cyst of testis (disorder) |
cysteamin 0,1 %, ögondroppar |
Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Cysteine carboxypeptidase |
Cysteine carboxypeptidase |
Cysteine proteinase |
Cysteine proteinase |
Cystic disease |
Fibrocystic change |
Cystoscopic extirpation of bladder lesion NOS |
Cystoscopy and destruction of bladder lesion |
Cystoscopy: [diagnostic NOS] or [unspecified check] |
Transurethral cystoscopy (procedure) |
Cytarabine 100mg injection (pdr for recon)+diluent |
Product containing only cytarabine in parenteral dose form (medicinal product form) |
cytarabin 100 mg, pulver till injektionsvätska, flaska |
Product containing only cytarabine in parenteral dose form (medicinal product form) |
Cytarabine 1g injection (pdr for recon)+diluent |
Product containing only cytarabine in parenteral dose form (medicinal product form) |
cytarabin 1 g, pulver till injektionsvätska, flaska |
Product containing only cytarabine in parenteral dose form (medicinal product form) |
brist på enzymet cytokrom P450 CYP2C9 |
Cytochrome P450 family 2 subfamily C member 9 poor metabolizer (finding) |
brist på enzymet cytokrom P450 CYP2D6 |
Cytochrome P450 family 2 subfamily D member 6 poor metabolizer (finding) |
Cytochrome-b reductase deficiency |
Dihydrolipoamide dehydrogenase deficiency |
Cytology of organ NOC |
Cytologic test |
Cytology of organ NOC NOS |
Cytologic test |
Cytophaga uliginosa |
Zobellia uliginosa (organism) |
Cytotoxic injection NOS |
Injection |
Cytotoxic injection NOS |
Injection |
DF-1 Group |
Capnocytophaga ochracea |
DHSS medical examination NOS |
Specialized medical examination |
DS1500 attendance allowance NOS |
Attendance allowance medical |
undersökning för assistansersättning enligt DS1500 |
Attendance allowance medical |
DS4 attend allowance exam NOS |
Attendance allowance medical |
Dacarbazine 200mg/vial injection |
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Daclizumab 25mg/5 mL solution |
Daclizumab only product in parenteral dose form |
daklizumab 25 mg/5 ml, injektionsvätska, lösning |
Daclizumab only product in parenteral dose form |
daklizumab 25 mg/5 ml, infusionskoncentrat |
Daclizumab only product in parenteral dose form |
dacron |
Polyethylene terephthalate (substance) |
Dacryocystorhinostomy and insertion of tube however further qualified |
Dacryocystorhinostomy and insertion of tube |
Dactylaria constricta var constricta |
Ochroconis constricta |
Daily |
Daily (qualifier value) |
Daktarin oral gel 15g |
Product manufactured as oromucosal dose form (product) |
Damaliscus dorcas |
Damaliscus pygargus (organism) |
fuktig miljö |
Damp environment |
Danaparoid sodium |
Product containing danaparoid (medicinal product) |
biverkning av natriumdanaparoid |
Adverse reaction to danaparoid (disorder) |
natriumdanaparoidallergi |
Allergy to danaparoid (finding) |
Dance therapy |
Dance therapy |
farlig miljö |
Dangerous environment |
tvådelat Dansac-stomisystem |
Two-piece ostomy system (physical object) |
Dantrolene sodium 20mg/vial injection |
Dantrolene sodium 20 mg powder for solution for injection vial |
mörkertremor |
Tremor |
Darrows infusionsvätska, lösning, påse 1 000 ml |
Product containing only potassium chloride and sodium chloride and sodium lactate (medicinal product) |
Darrows infusionsvätska, lösning, påse 500 ml |
Product containing only potassium chloride and sodium chloride and sodium lactate (medicinal product) |
Darrows infusionsvätska, lösning, påse |
Product containing only potassium chloride and sodium chloride and sodium lactate (medicinal product) |
Daruavir ethanolate |
Darunavir ethanolate (substance) |
dotter till patienten |
Daughter |
avisningsmedel |
Automotive de-icer (substance) |
Debaromyces |
Debaryomyces |
Debaromyces hansenii |
Debaryomyces hansenii |
Decreased 11-deoxy, 17-hydroxycorticosterone level |
11-deoxy, 17-hydroxycorticosterone level below reference range |
Decreased 11-deoxycorticosterone level |
11-deoxycorticosterone level below reference range (finding) |
Decreased 17-ketosteroids level |
17-ketosteroids level below reference range (finding) |
Decreased Q-T interval |
Shortened QT interval |
minskat rörelseomfång i fotled vid aktiv extension |
Decreased active range of ankle plantar flexion |
minskat rörelseomfång i fotled vid aktiv flexion |
Decreased active range of ankle dorsiflexion (finding) |
Decreased adrenal cortical hormone level |
Adrenal cortical hormone level below reference range |
Decreased adrenocorticotropic hormone level |
Adrenocorticotropic hormone level below reference range (finding) |
Decreased androgen level |
Androgen level below reference range |
Decreased anti-diuretic hormone level |
Anti-diuretic hormone level below reference range |
Decreased ascorbic acid |
Ascorbic acid below reference range (finding) |
Decreased biotin |
Biotin below reference range (finding) |
Decreased carboxyhemoglobin |
Carboxyhaemoglobin below reference range |
Decreased carotene |
Carotene below reference range |
Decreased corticosterone level |
Corticosterone level below reference range |
Decreased corticotropin releasing factor level |
Corticotropin releasing factor level below reference range (finding) |
Decreased cortisol level |
Cortisol level below reference range (finding) |
Decreased cortisone level |
Cortisone level below reference range |
Decreased cremasteric reflex |
Decreased cremasteric reflex |
Decreased epinephrine level |
Epinephrine level below reference range (finding) |
Decreased estradiol level |
Oestradiol level below reference range |
Decreased estriol level |
Oestriol level below reference range |
Decreased estrone level |
Oestrone level below reference range |
Decreased fibrinogen |
Fibrinogen below reference range (finding) |
Decreased flexor reflex |
Decreased flexor reflex |
Decreased folic acid |
Folic acid below reference range |
Decreased glucagon level |
Glucagon level below reference range |
Decreased hemoglobin |
Hemoglobin below reference range (finding) |
Decreased human chorionic gonadotropin level |
Human chorionic gonadotropin level below reference range (finding) |
Decreased human growth hormone level |
Human growth hormone level below reference range |
Decreased immunoglobulin |
Immunoglobulin below reference range (finding) |
Decreased insulin level |
Insulin level below reference range (finding) |
Decreased melanocyte stimulating hormone level |
Melanocyte stimulating hormone level below reference range |
Decreased methemoglobin |
Methemoglobin below reference range |
Decreased norepinephrine level |
Noradrenaline level below reference range |
Decreased oxytocin level |
Oxytocin level below reference range |
Decreased pantothenic acid |
Pantothenic acid below reference range |
minskat rörelseomfång i fotled vid passiv extension |
Decreased passive range of ankle plantar flexion (finding) |
minskat rörelseomfång i fotled vid passiv flexion |
Decreased passive range of ankle dorsiflexion (finding) |
Decreased pituitary follicle stimulating hormone |
Pituitary follicle stimulating hormone below reference range |
Decreased pituitary gonadotropin level |
Pituitary gonadotropin level below reference range (finding) |
Decreased pituitary luteinizing hormone level |
Pituitary luteinizing hormone level below reference range |
sänkt halt av polypeptidhormon |
Abnormal polypeptide hormone |
Decreased pregnanediol level |
Pregnanediol level below reference range (finding) |
Decreased pregnanetriol level |
Pregnanetriol level below reference range (finding) |
Decreased progesterone level |
Progesterone level below reference range (finding) |
Decreased prolactin level |
Prolactin level below reference range |
Decreased protein hormone level |
Serum proteins below reference range |